WO2006104137A1 - スクラーゼ活性阻害剤、グルコアミラーゼ活性阻害剤並びにそれらを含む食品及び飼料 - Google Patents

スクラーゼ活性阻害剤、グルコアミラーゼ活性阻害剤並びにそれらを含む食品及び飼料 Download PDF

Info

Publication number
WO2006104137A1
WO2006104137A1 PCT/JP2006/306261 JP2006306261W WO2006104137A1 WO 2006104137 A1 WO2006104137 A1 WO 2006104137A1 JP 2006306261 W JP2006306261 W JP 2006306261W WO 2006104137 A1 WO2006104137 A1 WO 2006104137A1
Authority
WO
WIPO (PCT)
Prior art keywords
palatinose
activity
sucrose
weight
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2006/306261
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
Jun Kashimura
Yukie Nagai
Tadashi Ebashi
Toshinao Goda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui DM Sugar Co Ltd
Original Assignee
Mitsui Sugar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Sugar Co Ltd filed Critical Mitsui Sugar Co Ltd
Priority to EP06730209A priority Critical patent/EP1864670A4/en
Priority to US11/887,342 priority patent/US20080206311A1/en
Publication of WO2006104137A1 publication Critical patent/WO2006104137A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30Artificial sweetening agents
    • A23L27/31Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
    • A23L27/32Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to a sucrase activity inhibitor and a dalcamylase activity inhibitor containing one or more saccharides selected from the group power consisting of palatinose, trehalulose and reduced palatinose.
  • the present invention also relates to food and feed comprising the sucrase activity inhibitor and optionally sucrose.
  • the present invention relates to foods and feeds comprising the darcoamylase activity inhibitor and optionally starch and Z or dextrin.
  • Patent Document 10 Japanese Patent Laid-Open No. 54-92909
  • Vitamin C granules 19.5 wt 0/0
  • a hard candy containing the agent of the present invention was produced with the following composition. First, crystalline palatinose, trehalulose syrup and water were added to a dissolution tank and dissolved by heating and stirring. Next, it is heated under reduced pressure to a temperature of 120 ° C under a pressure of 700 mmHg. , Vitamin P, and lemon flavor. After cooling to about 70-80 ° C, each grain was shaped to 4g and packaged individually.
  • FIG. 1 is a graph showing the sucrase activity inhibition strength by palatinose.
  • ⁇ 2] is a graph showing the sucrase activity inhibitory effect of the combination of test samples

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
PCT/JP2006/306261 2005-03-29 2006-03-28 スクラーゼ活性阻害剤、グルコアミラーゼ活性阻害剤並びにそれらを含む食品及び飼料 Ceased WO2006104137A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06730209A EP1864670A4 (en) 2005-03-29 2006-03-28 SUCRASE ACTIVITY INHIBITOR, GLUCOAMYLASE ACTIVITY INHIBITOR, AND THESE FOODSTUFF AND INCLUDING THEREOF
US11/887,342 US20080206311A1 (en) 2005-03-29 2006-03-28 Sucrase Activity Inhibitor, Glucoamylase Activity Inhibitor and Food and Feed Containing the Same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005095747 2005-03-29
JP2005-095747 2005-03-29
JP2005-284665 2005-09-29
JP2005284665A JP5000874B2 (ja) 2005-03-29 2005-09-29 スクラーゼ活性又はグルコアミラーゼ活性を阻害する剤

Publications (1)

Publication Number Publication Date
WO2006104137A1 true WO2006104137A1 (ja) 2006-10-05

Family

ID=37053393

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/306261 Ceased WO2006104137A1 (ja) 2005-03-29 2006-03-28 スクラーゼ活性阻害剤、グルコアミラーゼ活性阻害剤並びにそれらを含む食品及び飼料

Country Status (5)

Country Link
US (1) US20080206311A1 (enExample)
EP (1) EP1864670A4 (enExample)
JP (1) JP5000874B2 (enExample)
KR (1) KR20070120944A (enExample)
WO (1) WO2006104137A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103053900A (zh) * 2011-10-21 2013-04-24 松谷化学工业株式会社 血糖值的上升缓慢的糖质组成物及饮食品

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5152474B2 (ja) * 2007-05-29 2013-02-27 松谷化学工業株式会社 オリゴ糖、その製造方法、及びその用途
DE102008007072A1 (de) * 2008-01-31 2009-08-13 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Verfahren zur Herstellung fermentierbarer Getränke
JP2010053036A (ja) * 2008-07-31 2010-03-11 Mitsui Sugar Co Ltd 満腹感を持続させる剤及び該剤を含む飲食品
CN102665750B (zh) * 2009-11-30 2018-01-02 株式会社明治 对小肠有益的营养组合物
DE102010055577A1 (de) * 2010-12-21 2012-06-21 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Isomaltulose in Fondants
JP5943516B2 (ja) * 2012-08-27 2016-07-05 松谷化学工業株式会社 D−ソルボースを有効成分とする生体機能改善用甘味料
JP6694725B2 (ja) * 2015-02-16 2020-05-20 学校法人近畿大学 糖組成物製造方法及びインベルターゼ阻害剤
DE102019219323A1 (de) * 2019-12-11 2021-06-17 Südzucker AG Verfahren zur Herstellung einer eine Trehalulose-haltige Zusammensetzung enthaltenden Hartkaramelle

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001521900A (ja) * 1997-10-31 2001-11-13 シューズッカー アクチエンゲセルシャフト 高血糖症の治療のための二糖誘導体
JP2004315499A (ja) * 2002-11-18 2004-11-11 Shin Mitsui Sugar Co Ltd 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953920B2 (ja) * 1977-12-28 1984-12-27 東洋醸造株式会社 新規なアミノ糖化合物およびその製法
US5229276A (en) * 1990-10-31 1993-07-20 Mitsui Sugar Co., Ltd. Process for preparing trehalulose and isomaltulose
JPH0665080A (ja) * 1992-03-10 1994-03-08 Godo Shiyusei Kk α−グルコシダ−ゼ阻害剤を含有する、過血糖付随疾患の予防・治療剤、および保健食
JP3650705B2 (ja) * 1999-03-24 2005-05-25 サンスター株式会社 パラチニット含有食品
JP2000300212A (ja) * 1999-04-23 2000-10-31 Mitsui Sugar Co Ltd 運動に伴って起こる酸化的代謝を持続させる方法およびスポ−ツ用飲食物
JP2002012547A (ja) * 2000-06-28 2002-01-15 Ito En Ltd 糖質分解阻害剤、インスリン分泌抑制剤及び健康飲食物
JP4860840B2 (ja) * 2001-05-14 2012-01-25 三井製糖株式会社 集中力及び注意力を持続させる剤及び該剤を含む飲食物
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
JP2003155240A (ja) * 2001-11-16 2003-05-27 Shin Mitsui Sugar Co Ltd 集中力及び注意力を持続させる剤及び該剤を含む飲食物
EP1410721B2 (de) * 2002-10-17 2012-08-08 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Verfahren zur Herstellung einer Isomaltulose-haltigen Enteralnahrung
WO2005013720A2 (en) * 2003-07-23 2005-02-17 Cerestar Holding B.V. Isomaltulose or trehalose containing comestibles for sustained carbohydrate energy release and increased fat oxidation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001521900A (ja) * 1997-10-31 2001-11-13 シューズッカー アクチエンゲセルシャフト 高血糖症の治療のための二糖誘導体
JP2004315499A (ja) * 2002-11-18 2004-11-11 Shin Mitsui Sugar Co Ltd 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GODA T. ET AL.: "Hydrolysis of palatinose by rat intestinal sucrase-isomaltase complex", NIPPON EIYO, SHOKURYO GAKKAISHI, vol. 36, no. 3, 1983, pages 169 - 173, XP003006459 *
YAMADA K. ET AL.: "Inhibitory effects of D-tagatose on small intestinal disaccharidase", SHOKA TO KYUSHU, vol. 24, no. 2, 2002, pages 61 - 64, XP003006458 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103053900A (zh) * 2011-10-21 2013-04-24 松谷化学工业株式会社 血糖值的上升缓慢的糖质组成物及饮食品
JP2013087106A (ja) * 2011-10-21 2013-05-13 Matsutani Chem Ind Ltd 血糖値の上昇が緩やかな糖質組成物及び飲食品
CN103053900B (zh) * 2011-10-21 2016-04-06 松谷化学工业株式会社 血糖值的上升缓慢的糖质组成物及饮食品
US10021900B2 (en) 2011-10-21 2018-07-17 Matsutani Chemical Industry Co., Ltd. Carbohydrate composition and food and beverage producing gradual rise in blood glucose levels

Also Published As

Publication number Publication date
US20080206311A1 (en) 2008-08-28
JP2006306831A (ja) 2006-11-09
KR20070120944A (ko) 2007-12-26
JP5000874B2 (ja) 2012-08-15
EP1864670A1 (en) 2007-12-12
EP1864670A4 (en) 2009-04-15

Similar Documents

Publication Publication Date Title
Ibrahim Functional oligosaccharides: Chemicals structure, manufacturing, health benefits, applications and regulations
AU724947B2 (en) Method of increasing the sweetening power and enhancing the taste of a mixture of high-intensity sweeteners
CA2473209C (en) Stimulation of the immune system with polydextrose
AU2010237335B2 (en) Trehalulose-containing composition, its preparation and use
TWI392496B (zh) 具有治療、預防或改善糖尿病或糖尿病併發症之效果的組成物及含其之飲料
JP2005531611A (ja) ガラクトシル・イソマルト、その製造方法及び使用
CN102186886A (zh) 新型聚葡萄糖材料
TWI303992B (enExample)
JP5442243B2 (ja) 腎障害抑制剤
JP2018024619A (ja) 持久力向上剤
WO2006104137A1 (ja) スクラーゼ活性阻害剤、グルコアミラーゼ活性阻害剤並びにそれらを含む食品及び飼料
JP2006512298A (ja) 水素化形態の縮合パラチノース
JP2006306831A5 (enExample)
WO2004089964A1 (ja) 脂質調節剤及びその用途
WO2017047706A1 (ja) 血糖値上昇抑制剤及びこれを含んでなる経口組成物
KR101498592B1 (ko) 폴리덱스트로스를 함유한 물엿 조미료의 제조방법
KR100486630B1 (ko) 변비와 장기능 개선을 위한 기능성 식이섬유 보충용 식품및 그 제조방법
WO2011071179A1 (ja) 持続型エネルギー補給剤及び飲食品
JP2010195734A (ja) フィチン酸、カルボン酸、および糖類の相乗効果による脂肪吸収抑制作用を有する組成物
JP2010059105A (ja) 炎症性腸疾患の予防又は治療剤
CN112868973A (zh) 一种含有l-阿拉伯糖的甜味剂及其制备方法和应用
JP4673753B2 (ja) マンノオリゴ糖を含有する血清脂質改善剤
JP7141387B2 (ja) 生体内フェノール化合物低減剤
JP2005289847A (ja) 血糖値上昇抑制剤
JP6303714B2 (ja) Dna損傷抑制剤及びその製造方法

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680010292.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1020077020224

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 11887342

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006730209

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU

WWP Wipo information: published in national office

Ref document number: 2006730209

Country of ref document: EP